Global Point-of-care Glucose Testing Market

Point-Of-Care Glucose Testing Market Size, Share, Growth Analysis, By Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings), By Region - Industry Forecast 2026-2033

Report ID: SQMIG15E2398 | Region: Global | Published Date: November, 2025
Pages: 184 | Tables: 64 | Figures: 75

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Point-of-care Glucose Testing Market size was valued at USD 3.58 Billion in 2024 and is poised to grow from USD 3.74 Billion in 2025 to USD 5.19 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026–2033).

    The global point-of-care glucose testing market is a highly competitive landscape with the presence of several key players. These companies strive to maintain their market position by focusing on product innovation, strategic partnerships, and geographical expansion. Key players in the competitive landscape of the global point-of-care glucose testing market continuously strive to introduce advanced technologies, improve product efficacy, and enhance user experience. They also engage in strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their geographical presence. With a focus on innovation and customer-centric approaches, these companies contribute significantly to the growth and development of the point-of-care glucose testing market. 'Abbott Laboratories (USA) ', 'Roche Holding AG (Switzerland) ', 'Ascensia Diabetes Care Holdings AG (Switzerland) ', 'Dexcom, Inc. (USA) ', 'Medtronic plc (Ireland) ', 'LifeScan, Inc. (USA) ', 'Becton, Dickinson and Company (BD) (USA) ', 'ACON Laboratories, Inc. (USA) ', 'Nova Biomedical Corporation (USA) ', 'ARKRAY, Inc. (Japan) ', 'Trividia Health, Inc. (USA) ', 'PTS Diagnostics (USA) ', 'Nipro Corporation (Japan) ', 'Ypsomed Holding AG (Switzerland) ', 'Sanofi S.A. (France) ', 'EKF Diagnostics Holdings plc (UK) ', 'Prodigy Diabetes Care, LLC (USA) ', 'Bayer AG (Germany) ', 'Danaher Corporation (USA) ', 'Platinum Equity Advisors, LLC (USA)'

    The increasing global incidence of diabetes is a major driver of the point-of-care glucose testing market. According to the International Diabetes Federation, the number of adults living with diabetes is expected to reach 700 million by 2045. This surge in diabetes cases necessitates regular glucose monitoring, leading to a higher demand for point-of-care testing devices.

    Integration with Digital Health Platforms: The integration of point-of-care glucose testing devices with digital health platforms and electronic health records is a significant trend in 2022. This integration enables seamless data transfer, analysis, and real-time monitoring of glucose levels. It empowers patients to actively participate in their diabetes management and allows healthcare professionals to make informed treatment decisions based on comprehensive patient data.

    North America holds the largest market share in the global point-of-care glucose testing market. This dominance can be attributed to several factors, including the high prevalence of diabetes in the region, well-established healthcare infrastructure, and favorable reimbursement policies. The presence of key market players, technological advancements, and the adoption of innovative glucose testing devices contribute to the region's leadership position. Additionally, increasing awareness among healthcare professionals and patients about the benefits of point-of-care glucose testing drives market growth in North America.

    Related Reports

    Glucose Tolerance Test Market
    Buy Now GET FREE SAMPLE
    Blood Glucose Monitoring Devices Market
    Buy Now GET FREE SAMPLE
    Continuous Glucose Monitoring Devices Market
    Buy Now GET FREE SAMPLE
    Blood Glucose Test Strips Market
    Buy Now GET FREE SAMPLE
    Point Of Care Diagnostics Market
    Buy Now GET FREE SAMPLE
    Diabetes Care Devices Market
    Buy Now GET FREE SAMPLE
    Diabetes Device Market
    Buy Now GET FREE SAMPLE
    Diabetes Care Devices and Drugs Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Point-of-care Glucose Testing Market

    Report ID: SQMIG15E2398

    $5,300
    BUY NOW GET FREE SAMPLE